Related Experiment Video
Updated: Nov 8, 2025

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Reactive angioendotheliomatosis associated with antiphospholipid syndrome
Amy E Wells, Reesa L Monir1, Nicole R Bender
1Department of Dermatology, University of Florida College of Medicine, Gainesville, FlL. rlendry@ufl.edu.
Abstract:
Reactive angioendotheliomatosis (RAE) is an uncommon, benign, antiproliferative condition associated with systemic diseases that may cause occlusion or inflammation of the vascular lumina. A link between antiphospholipid syndrome (APS) and RAE has been reported a few times in the literature. Herein, we present a unique case of RAE diagnosed in a patient with primary APS who was well-managed on warfarin and rituximab with no recent thrombotic events. As RAE can precede or follow a diagnosis of APS, the presence of the condition indicates a need to workup for APS and to ensure those with the condition are adequately anticoagulated. However, as demonstrated in this case, the condition can still occur in patients who are adequately anticoagulated.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Rheumatic Heart Disease I: Introduction
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

